SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037708
Filing Date
2020-08-06
Accepted
2020-08-06 16:02:11
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q igms-10q_20200630.htm 10-Q 2549463
2 EX-31.1 igms-ex311_6.htm EX-31.1 19008
3 EX-31.2 igms-ex312_9.htm EX-31.2 17503
4 EX-32.1 igms-ex321_7.htm EX-32.1 9501
5 EX-32.2 igms-ex322_8.htm EX-32.2 9496
  Complete submission text file 0001564590-20-037708.txt   7405077

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT igms-20200630.xml EX-101.INS 1430014
7 XBRL TAXONOMY EXTENSION SCHEMA igms-20200630.xsd EX-101.SCH 44972
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE igms-20200630_cal.xml EX-101.CAL 47320
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igms-20200630_def.xml EX-101.DEF 202460
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20200630_lab.xml EX-101.LAB 375954
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20200630_pre.xml EX-101.PRE 302002
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 201081459
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences